Open Access

Sumo and the cellular stress response

Cell Division201510:4

https://doi.org/10.1186/s13008-015-0010-1

Received: 10 June 2015

Accepted: 12 June 2015

Published: 20 June 2015

Abstract

The ubiquitin family member Sumo has important functions in many cellular processes including DNA repair, transcription and cell division. Numerous studies have shown that Sumo is essential for maintaining cell homeostasis when the cell encounters endogenous or environmental stress, such as osmotic stress, hypoxia, heat shock, genotoxic stress, and nutrient stress. Regulation of transcription is a key component of the Sumo stress response, and multiple mechanisms have been described by which Sumo can regulate transcription. Although many individual substrates have been described that are sumoylated during the Sumo stress response, an emerging concept is modification of entire complexes or pathways by Sumo. This review focuses on the function and regulation of Sumo during the stress response.

Keywords

Sumo Stress response Transcription DNA damage response ER stress Viral infections Nutrient stress SIMs

Introduction

Several small ubiquitin-like molecules were identified during the 1990s, including Sumo (Small ubiquitin-like modifier) [1]. Despite limited sequence similarity, Sumo is structurally related to ubiquitin with a similar protein fold. [2], although the distribution of charged residues on the surface of the Sumo molecule differs from that of ubiquitin [3]. The budding yeast Saccharomyces cerevisiae only expresses a single form of Sumo (encoded by the SMT3 gene), whereas mammalian cells express four; Sumo1, −2,-3,-4.

During recent years it has become clear that Sumo has important functions in normal cell homeostasis, in large part through regulation of transcription (reviewed in Chymkowitch et al., submitted). However, Sumo is also very important for the cellular stress response, and many cellular stresses result in increased formation of Sumo conjugates. Sumo can be covalently attached to a large number of proteins to regulate their fate, localization and function. The physiological significance of many of these sumoylation events remains unknown, which is in part due to the fact that Sumo can be attached to multiple components of an entire complex, and preventing the attachment of Sumo to a single component of the complex often has little or no clear effect. Furthermore, when a given Sumo site is mutated, Sumo is sometimes attached to other sites in the same substrate with apparently little effect on the overall outcome. In contrast to the ubiquitination machinery, the sumoylation machinery only consists of very few components, raising the question how specificity is achieved and how the activity of the Sumo pathway is regulated.

The scope of this review is to provide an overview of the function of Sumo in the cellular stress response, in particular transcription, and to highlight a number of key questions that remain to be answered.

Protein sumoylation

The sumoylation machinery

Similar to ubiquitination, sumoylation occurs through a series of biochemical steps catalyzed by a set of well-conserved enzymes (Fig. 1 and Table 1). In the first step, Sumo, which is expressed as an inactive precursor protein, is processed by cysteine-specific Sumo proteases (ULPs in yeast, SENPs in mammals) that remove a small peptide from the C-terminus. This exposes a di-glycine motif, which is subsequently linked to the E1 enzyme, a dimer consisting of Sae1 and Sae2 (Aos1 and Uba2 in S. cerevisiae). This step involves the covalent attachment of Sumo to a reactive cysteine residue in Sae2 through ATP-dependent thioesterification [4]. Through thioester linkage, Sumo is then transferred to a cysteine residue of the E2 conjugating enzyme Ubc9. In vitro, the E2 enzyme is sufficient for conjugating Sumo to a lysine residue in the substrate, although it is believed that this process is facilitated by E3 ligases in vivo [4]. For instance, E3 ligases can serve as a scaffold that brings together Sumo-charged Ubc9 and the substrate, thereby promoting efficiency and specificity of the sumoylation process. Alternatively, E3 ligases can stimulate the E2 enzyme to transfer Sumo to its substrate.
Fig. 1

Overview of the Sumo pathway

Table 1

The sumoylation machinery in S. cerevisiae and mammals

Protein function

S. cerevisiae

H. sapiens

Sumo

Smt3

SUMO-1,-2,-3

E1 activating enzyme

Aos1•Uba2

Sae1•Sae2

E2 conjugating enzyme

Ubc9

UBC9

E3 ligase

Siz1, Siz2, Cst9, Mms21

PIAS1,-2,-3,-4; MZIZ1; NSE2; RanBP2; Pc2; MUL1; TOPORS; HDAC4,-7; TRAF7; FUS; RSUME

Sumo protease

Ulp1, Ulp2

SENP1,-2,-3,-4,-5,-6,-7; DESI1,-2; USPL1

An important aspect of protein sumoylation is that it is a dynamic and reversible process. Sumoylated proteins can be desumoylated by the same proteases that convert the inactive Sumo precursor to its reactive form (ULPs/SENPs). These enzymes have important functions in spatial regulation of Sumo turnover [5], which is crucial for many cellular processes including chromosome cohesion, mitosis and transcription [68]. In S. cerevisiae, the activity of Ulp1 and Ulp2 towards sumoylated proteins is in large part dependent upon their localization; Ulp1 activity in particular appears to be highly localized at nuclear pore complexes, whereas Ulp2 may be more active towards proteins located in the nucleoplasm [9, 10]. However, how the enzymatic activity of Sumo proteases is regulated is currently not well understood (also see below).

Consensus motifs for sumoylation

Sumoylation of substrates preferentially occurs on a lysine residue in the canonical Sumo consensus motif ΨKx(D/E), in which Ψ is a large hydrophobic residue and x is any amino acid followed by an acidic residue [11]. The hydrophobic and acidic residues promote stability of the interaction between the substrate and the E2 enzyme [1214]. Several variations on this sumoylation motif have been identified, including so-called negatively charged amino acid-dependent Sumo motifs (NDSMs) and phosphorylation-dependent Sumo motifs (PDSMs). PDSMs are basically extended versions of the canonical Sumo motif (ψKx(D/E)xxSP), and phosphorylation of this motif by proline-directed kinases generally increases sumoylation efficiency [15]. Phosphorylated PDSMs and NDSMs likely promote sumoylation efficiency by increasing the stability of the interaction between Ubc9 and the substrate, because the negatively charged phosphate (in case of PDSM) or the negatively charged amino acids (NDSM) interact with basic residues on the surface of Ubc9 [15, 16]. It is important to note that sumoylation can also occur on lysines that do not conform to known Sumo consensus motifs [1719], such as the well-studied K164 Sumo site in PCNA [20], and data from high-throughput studies indicate that non-consensus sumoylation may be a relatively common event [19, 21]. How these sites are recognized by the sumoylation machinery remains to be determined.

Sumo chains

While conjugated Sumo is probably best studied in its a monomeric form, Sumo can also form oligomeric chain structures. In S. cerevisiae, these are primarily formed through K15 linkage (K11 in mammalian Sumo-2/3), which is part of the canonical Sumo consensus motif, and requires the E1 enzyme and Ubc9 [22, 23]. Sumo chains are best characterized in their role as an indirect protein degradation signal; they can recruit conserved E3 ubiquitin ligases known as Sumo targeted ubiquitin ligases (STUbLs), which subsequently ubiquitinate the polysumoylated protein to target it for proteasomal degradation [24]. Some examples of STUbL targets are PML, c-Myc, the viral Tax protein, the Drosophila transcriptional repressor Hairy, the S. cerevisiae basal transcription factor Mot1, and the A. thaliana transcriptional repressor CDF2 [2529]. Apart from its function in protein degradation, the physiological significance of Sumo chains remains poorly understood. A global study of Sumo chain function in S. cerevisiae indicates that Sumo chains are involved in regulation of transcription and ordering of chromatin structure [30], although the molecular mechanisms have not been characterized in detail.

Sumo interaction motifs

Sumoylation of proteins adds a bulky moiety that can affect the interaction with other proteins. For instance, sumoylation of PCNA on K127 prevents the interaction between PCNA and the chromatin cohesion protein Eco1 [31]. In another example, the covalent conjugation of SUMO-1 to lysine 341 of the base excision repair enzyme thymine DNA glycosylase (TDG) blocks the interaction with the histone acetyltransferase CBP/p300 [32]. However, most studies have focused on the function of Sumo in promoting protein-protein interactions. Here, Sumo can provide an interaction surface for specific binding partners, which typically interact with Sumo through a Sumo interaction motif (SIM). The first reported SIM was identified through a two-hybrid screen that used the p53 family member p73α as bait [33]. It was found that p73α became sumoylated in yeast, and this sumoylated form of p73α subsequently interacted with various mammalian interaction partners. By comparing common motifs in these interaction partners, it was found that they share a common ΦΦxSxS[D/E][D/E][D/E], where Φ is a hydrophobic amino acid [33]. Because this motif is centered on the two serines it became known as the ‘SxS’ motif. However, it was later found that these two serines are not critical for Sumo binding, and that the two hydrophobic amino acids play a much more important role; in fact, NMR spectroscopic characterization of the interaction between mammalian SUMO-1 and peptides derived from known Sumo binding proteins identified a hydrophobic core with the consensus [V/I]x[V/I][V/I] [34]. Subsequent studies confirmed the importance of this hydrophobic core, and structural studies have shown that in complex with Sumo the hydrophobic side chains of the SIM interact with a hydrophobic pocket on the SUMO surface [35, 36]. This canonical SIM is often flanked by acidic amino acids [37, 38], not unlike the originally reported SxS motif [33]. In some cases, phosphorylated serine residues fulfill the function of these acidic amino acids. These phospho-SIMs have been identified in PML, EXO9 and in the PIAS proteins, which are phosphorylated by the constitutively active casein kinase 2 (CK2) [39]. The phosphorylated residues in the SIM interact with a lysine residue on the Sumo surface to stabilize the SIM-Sumo interaction [39]. In addition to providing the cell with a mechanism for temporal and spatial control of protein sumoylation, phospho-SIMs may add specificity to selection of appropriate Sumo substrates.

Interestingly, the Sumo pathway often targets multiple components of protein complexes and pathways [4042]. This phenomenon of protein group sumoylation was first described for yeast septins and was more recently also observed in the DNA checkpoint/repair pathways. The exact physiological significance of protein group sumoylation is presently not clear, although it has been proposed that multiple Sumo-SIM interactions serve as a ‘Sumo glue’ to stabilize the integrity of the complex [42]. Perhaps protein group sumoylation, in which multiple relatively weak Sumo-SIM interactions cooperate to provide increased complex stability, is important for buffering the system. More specifically, it is likely that significant Sumo noise exists in the cell, because sumoylation is a common event (up to 10% of all mammalian proteins may be Sumo targets [43]); potential SIMs are ubiquitous (4892 instances of the [V/I]x[V/I][V/I] motif can be found in the S. cerevisiae proteome, totaling 2919 proteins); and under normal growth conditions a large pool of free Sumo exists in the cell, which could compete with sumoylated proteins for binding to SIMs. To overcome this noise, protein group sumoylation may be a strategy of the cell to increase the signal-to-noise ratio of Sumo-SIM interactions to generate a consistent output.

The Sumo stress response

Early studies with mammalian and yeast cells found that Sumo is important for the cellular response to stress, such as heat shock, DNA damage, oxidative stress and ethanol stress [44, 45]. Although Sumo is crucial for the stress response in plants, here I will mainly focus on studies conducted in yeast and vertebrates, referring the reader to recent reviews on Sumo in the plant stress response [4648].

DNA damage response

Sumo has been studied extensively in the context of DNA damage, and except for a few specific examples I will not discuss this in great detail here and instead refer the reader to recent reviews [49, 50]. One of the best known targets of Sumo in the DNA damage response is PCNA[20]. PCNA is a trimeric complex that functions as a sliding clamp and processivity factor for DNA polymerases. In response to endogenous and exogenous DNA damage PCNA can be modified by ubiquitin and Sumo [20, 51] (Fig. 2). Sumoylation occurs preferentially on the evolutionarily conserved K164, and to a lesser extent on the yeast-specific residue K127 [20]. Sumoylated PCNA recruits the helicase Srs2, which has a SIM in its extreme C-terminus. Srs2 is an inhibitor of homologous recombination (HR) [52, 50, 53], and recruitment of Srs2 is believed to suppress undesirable recombination events during chromosome replication [54]. Srs2 itself is also a target of Sumo [55], and sumoylation of Srs2 appears to interfere with binding of Srs2 to sumoylated PCNA [56], although the exact physiological consequences for the DNA replication and repair process remain unclear.
Fig. 2

Regulation of PCNA by ubiquitin and Sumo. When cells are treated with high doses of MMS, PCNA becomes Sumo-modified primarily on K164 and to a lesser extent K127, resulting in recruitment of HR inhibitor Srs2. At lower levels of DNA damage PCNA is ubiquitinated mainly on K164 (and to a lesser degree also on other sites [113, 51]). This promotes lesion bypass in case of monoubiquitination, whereas polyubiquitinated PCNA induces template switching and error-free DNA repair

In addition to PCNA and Srs2, many other DNA damage response proteins are sumoylated in response to DNA damage [50, 57]. A recurrent theme appears to be protein group sumoylation [40, 42]. For instance, exposure of single stranded DNA (ssDNA) induces sumoylation of several proteins involved in HR, which is thought to promote DNA double strand break repair. For at least some of these proteins, simply localizing to the chromatin compartment is sufficient for sumoylation to occur, probably because it results in their colocalization with the chromatin-bound E3 ligase Siz2. Why Siz2 specifically sumoylates HR proteins and not any other chromatin-bound protein remains to be understood.

Viral infections

Infections with pathogens like viruses trigger a major stress response. Interferon (IFN) plays a central role in the response to viral infections. At the cellular level, IFN has a number of effects, most notably an increase in the number and size of so-called promyelocytic leukemia protein-nuclear bodies (PML-NBs). PML-NBs are dynamic nuclear substructures that consist of a very large number of proteins centered around the PML protein, which is essential for organizing these proteins into PML-NBs [58, 59]. Although the PML protein has been extensively studied in the context of acute promyelocytic leukemia, in which it is fused to the retinoic acid receptor to drive cancer cell proliferation and survival, in healthy cells it fulfills many functions essential for normal cell homeostasis. For instance, PML-NBs have been implicated in transcription, mRNA transport, the DNA damage response, telomere maintenance, the cellular stress response, apoptosis, stem cell maintenance and senescence [60, 61, 59]. PML-NBs also serve an important function in the antiviral response [60]. For instance, PML−/− mice exhibit increased viral load after infection with lymphocytic choriomeningitis virus (LCMV) and vesicular stomatitis virus (VSV) [62]. One way PML-NBs inhibit VSV infections is by recruiting and activating p53 to induce apoptosis, thereby killing the infected cell to protect the organism [60].

Sumo is a key regulator of PML function [59]. PML directly binds Ubc9, resulting in sumoylation on at least three lysines, K65, K160 and K490. Interestingly, PML has Sumo E3 ligase activity [63], which may mediate sumoylation of many components of PML-NBs [59]. It is believed that protein group sumoylation of these factors promotes the assembly of PML-NBs through multiple Sumo-SIM interactions [59] (Fig. 3a). Indeed, sumoylation of PML is essential for formation of PML-NBs, and a non-sumoylatable PML mutant fails to recruit key components of PML-NBs, including the transcriptional regulators SP100 and DAXX [59].
Fig. 3

Viruses can target the Sumo pathway to disrupt PML-NBs. a, Several components of PML-NBs are targets of Sumo, and multiple Sumo-SIM interactions may promote complex stability. b, The HSV viral protein ICP0 can function as a STUBL to degrade sumoylated PML, thereby disrupting structural integrity of PML-NBs

The importance of Sumo in the antiviral stress response is highlighted by the fact that sumoylation of PML increases upon infection with poliovirus, leading to recruitment of p53 and induction of apoptosis [64]. Not surprisingly, viruses have developed several mechanisms that disrupt PML-NBs, some of which target the sumoylation machinery. For instance, the chicken embryo lethal orphan (CELO) virus, which is an avian adenovirus, expresses a protein called Gam-1. Gam-1 blocks the sumoylation pathway by inhibiting formation of the E1-SUMO thioester-intermediate and by promoting proteasomal degradation of E1 and E2 proteins [65, 66].

Two other examples of viral proteins that target the Sumo pathway to disperse PML-NBs are the herpes simplex virus ICP0 protein and the human cytomegalovirus IE1 protein. Both these proteins interfere with sumoylation of PML, resulting in disassembly of PML-NBs [67]. ICP0 is believed to function as a STUbL that specifically binds Sumo-modified proteins including PML, resulting in their ubiquitination to target them for proteasomal degradation (Fig. 3b). Many other viruses have developed mechanisms that thwart the PML-NB antiviral defense system [68, 69]. Taken together, these studies show that Sumo plays an important role in the cellular antiviral stress response.

Endoplasmic reticulum (ER) stress response

Anomalies in ER function can result in the accumulation of misfolded proteins, which is often referred to as ER stress. ER stress results in activation of the unfolded protein response (UPR), which aims to re-establish cellular homeostasis by reducing the amount of unfolded proteins. Notably, while the UPR promotes cell viability at low doses of ER stress, it can also induce apoptosis when ER stress is not mitigated.

As illustrated in Figure 4, the UPR consists of three branches, i.e. inositol-requiring protein 1 (IRE1), protein kinase RNA-like ER kinase (PERK) and activating transcription factor 6 (ATF6) [70]. IRE1 contains both a kinase and an endoribonuclease domain. ER stress induces dimerization and autophosphorylation of IRE1, leading to activation of the cytosolic RNase domain. The RNase domain subsequently excises a small intron from the mRNA encoding the transcription factor X box-binding protein 1 (XBP1). This alters the reading frame of the mRNA, resulting in translation of the active transcription factor, known as ‘spliced XBP1’ (XBP1s). XBP1s then activates its target genes, which have important functions in the ER-associated protein degradation (ERAD) pathway, ER protein import, protein folding, and lipid synthesis [70].
Fig. 4

Sumo and the ER stress response. Unfolded proteins trigger the ER stress response, inducing processing of XBP mRNA by Ire1, ultimately yielding active XBP1s. Sumoylation of XBP1s and the physical interaction with Ubc9 inhibit its transcriptional activity

Interestingly, the Sumo pathway has multiple effects on the UPR. For instance, in mammalian cells XBP1s is sumoylated by PIAS2 on two lysines in the C-terminal transactivation domain, which inhibits the transcriptional activity of XBP1s [71]. Upon ER stress, the Sumo protease SENP1 desumoylates XBP1s to promote its transcriptional activity [72]. This effect of Sumo on XBP1 appears to be conserved in C. elegans [73]. Furthermore, mRNA encoding Sumo is degraded upon ER stress in Drosophila [74], and although the physiological consequences remain unknown, it is tempting to speculate that depletion of Sumo further boosts the activity of XBP1s. Finally, binding of mammalian Ubc9 to the leucine zipper motif of XBP1s increases XBP1s stability to enhance its transcriptional output, although this effect seems to be independent of the catalytic activity of Ubc9 [75]. Together, these findings show that the Ubc9-Sumo pathway has a negative effect on the ER stress response.

Regulation of transcription by Sumo

We have recently reviewed the diverse functions of Sumo in transcriptional regulation during normal growth conditions (Chymkowitch et al., submitted), and here I will mainly focus on regulation of transcription during cell stress.

Sumo is best known for its inhibitory function in transcription [76]. Several mechanisms have been described by which Sumo can inhibit transcription (Fig. 5). For instance, as has been described for the transcription factor Atf7 [77], Sumo can inhibit nuclear entry of transcription factors (Fig. 5a); it can prevent recruitment of general transcription factors (Fig. 5b); or it can block binding of transcription factors to specific sequences in the promoter (Fig. 5c). The sumoylation machinery can also inhibit transcription by competing for lysines that are targets for other modifications associated with transcriptional activation, such as acetylation, methylation or ubiquitination (Fig. 5d). This has been reported for STAT5A, where inhibitory sumoylation competes with an activating acetyl modification of K696 [78]. In a related mechanism, Sumo can prevent ubiquitin-mediated degradation of transcriptional inhibitors (Fig. 5e), as was described for IκBα [79]. IκBα is an inhibitor of the transcription factor NFκB, and IκBα can be ubiquinated on K21, which results in its proteasomal degradation. This relieves inhibition of NFκB, which subsequently activates transcription. However, K21 of IκBα is also a target for sumoylation, and Sumo-modified IκBα prevents ubiquitin-mediated degradation of IκBα, thereby preventing activation of NFκB [79]. Sumoylation of transcription factors can also result in recruitment of transcriptional repressors (Fig. 5f). An example of this mechanism is sumoylation of the transcription factor Elk-1, which results in recruitment of HDAC-2, which silences chromatin by deacetylating histones [80]. Transcriptional repressors can themselves be activated by sumoylation to create a repressive chromatin environment (Fig. 5g); for example, sumoylation of HDAC1 promotes transcriptional repression in vivo [81].
Fig. 5

Multiple mechanisms of transcriptional regulation by Sumo. a, Sumoylation prevents nuclear entry. b, Sumo prevents recruitment of general transcription factors (GTFs). c, Sumo inhibits promoter binding of the transcription factor. d, Sumo competes with other modifications that activate transcription. e, Sumo prevents degradation of an inhibitor of a transcription factor. f, Sumo recruits a transcriptional repressor that silences the local chromatin environment. g, Sumoylation increases the activity of a transcriptional repressor to inhibit transcription

Sumo-mediated inhibition of transcription is likely to be an important aspect of the cellular stress response. For instance, various stresses including heat shock, ethanol treatment and osmotic stress induce PIAS-mediated sumoylation of c-Myb, which results in inhibition of its transcriptional activity [82]. Since c-Myb is a major regulator of cell proliferation, unfavorable conditions may induce sumoylation of c-Myb to switch off the transcriptional programs required for cell proliferation.

Sumo can also activate transcription during cell stress. For instance, sumoylation of the heat shock transcription factors HSF1 and HSF2 increases their DNA binding activity, resulting in increased expression of heat shock proteins which provide protection against protein-damaging stress [83, 84]. Another example is the activation of NFκB in response to genotoxic stress. Genotoxic stress induces sumoylation and nuclear localization of NEMO, an activator of the IκB kinase IKK. This NEMO-induced IKK activation leads to phosphorylation of the NFκB inhibitor IκB, resulting in proteasomal degradation of IκB and activation of NFκB to transcribe pro-survival genes [85, 86].

Together, these studies illustrate the complexity of Sumo’s function in regulating transcription during the cellular stress response, and it is largely unclear how specificity is achieved in this process (also see below).

Sumo and the nutrient response

One major source of stress is a limitation in nutrient availability. Maintaining cellular homeostasis in the face of changes in nutrient supply is essential for the growth and development of all organisms, from unicellular microorganisms to higher eukaryotes. Cellular mechanisms have evolved that sense environmental alterations and evoke responses that act to preserve homeostasis. When a cell detects a reduction in its nutrient supply, it activates signal transduction pathways that elicit integrated responses that alter cell metabolism by reducing biosynthesis and increasing catabolism, and that mobilize utilization of alternative nutrient sources. One key element of the response to nutrient starvation is rewiring of gene expression programs. Target of rapamycin complex 1 (TORC1), a large protein complex that contains the Tor kinase, play a central role in the cellular response to nutrient status [8789]. TORC1 activity strongly depends on nutrient availability, in particular nitrogen. Under nitrogen-rich conditions, TORC1 promotes growth and proliferation-related processes, like protein synthesis, ribosome biogenesis, and tRNA synthesis, while inhibiting catabolic processes, like autophagy [8789]. Conversely, inhibition of TORC1 activity by nutrient depletion (or addition of the TORC1-specific inhibitor rapamycin) results in a metabolic switch from anabolism to catabolism [8789]. This involves many cellular processes, including rewiring of transcriptional programs [87, 90]. An important set of genes whose expression depends upon TORC1 includes genes involved in regulation of translation, such as the RNAPII-transcribed ribosomal protein genes (RPGs) and the RNAPIII-transcribed tRNA genes. In S. cerevisiae, TORC1 activates RPG transcription by promoting phosphorylation of the transcription factors Sfp1 and Ifh1, leading to their recruitment to PRG promoters where they activate transcription together with several other transcription factors, including Rap1 and Fhl1 (Fig. 6a) [9194]. In addition, TORC1 regulates transcription of RNAPIII-dependent genes by phosphorylating the transcriptional repressor Maf1, which results in nuclear exclusion of Maf1 (Fig. 6a) [88]. Nutrient stress results in inactivation of TORC1, leading to dephosphorylation of Sfp1, Ifh1 and Maf1. Subsequently, dephosphorylated Sfp1 and Ifh1 leave RPG promoters, resulting in loss of RPG transcription, whereas dephosphorylation of Maf1 causes it to enter the nucleus where it binds and inhibits RNAPIII to block transcription of tRNA genes (Fig. 6b) [88, 89]. This ultimately results in downregulation of the translational capacity of the cell until nutrient conditions improve [89].
Fig. 6

Regulation of pro-growth genes by Sumo. a, in the presence of sufficient nutrients, TORC1 and Ubc9 in transcription of pro-growth genes like RPGs and tRNA genes. TORC1 increases phosphorylation of Sfp1 and Ifh1, leading to their recruitment to PRG promoters. Ubc9 sumoylates Rap1, which enhances recruitment of TFIID to RPGs. Ubc9 also sumoylates RNAPIII components, which most likely is required for efficient tRNA transcription. TORC1 increases phosphorylation of Maf1, resulting in its nuclear exclusion. b, During nutrient stress TORC1 is inactive, leading to dephosphorylation of Sfp1 and Ifh1, which are then released from RPG promoters. Maf1 also becomes dephosphorylated, resulting in its nuclear entry where it binds and inhibits RNAPIII. At least in mammals Maf1 is also sumoylated, which contributes to its repressive effect on RNAPIII. Whether this also occurs in yeast is unknown

We recently found that nutrient stress profoundly affects cellular sumoylation patterns in yeast [95]. Nutrient stress particularly inhibits sumoylation of several transcription factors, especially components of the RNAPIII polymerase. Preventing sumoylation of RNAPIII results in strongly reduced tRNA expression levels [95]. Although the molecular mechanism remains to be solved, these findings indicate that sumoylation of RNAPIII is required for its activity, and that nutrient stress inhibits tRNA transcription by preventing sumoylation of RNAPIII [95]. This may be conserved in human cells, because several RNAPIII components have been identified as Sumo targets in high-throughput proteomic studies, although the functional consequences of these modifications have not been studied [9699].

Interestingly, in human cells Sumo is also associated with inhibition of RNAPIII-dependent transcription upon nutrient stress. Specifically, downregulation of RNAPIII during nutrient starvation requires sumoylation of Maf1, and cells expressing a non-sumoylatable mutant of Maf1 do not fully repress tRNA transcription during starvation [100]. These studies indicate that Sumo may differentially regulate RNAPIII activity, although more studies are required to fully understand how Sumo regulates RNAPIII.

Another yeast transcription factor that is regulated by Sumo is Rap1 [95, 101]. Rap1 becomes sumoylated on multiple sites, and Sumo increases the transcriptional activity of Rap1 at RPGs by promoting the recruitment of TFIID [95]. Although the exact molecular mechanism of TFIID recruitment to sumoylated Rap1 remains to be revealed, most components of the TFIID complex contain one or several SIMs, indicating that Sumo-SIM interactions may be important.

Paradoxically, whereas nutrient stress results in decreased RPG transcription, Rap1 sumoylation is increased under these conditions [95]. This is potentially the result of a homeostatic feedback loop, where the cell senses a decrease in its translational capacity and responds by attempting to restore RPG transcription by sumoylating Rap1. Indeed, Rap1 sumoylation is essential for maintaining a basal rate of RPG transcription under nutrient stress, and preventing Rap1 sumoylation during nutrient stress completely abolishes RPG transcription, causing a strong decrease in cell viability [95].

Regulation of RPGs by Sumo is conserved in mammalian cells, although the critical target is not the human homolog of Rap1 but rather the transcription factor scaffold attachment factor b1 (SAFB1). Together, these studies show that Sumo plays an important role in promoting cell growth and proliferation and that it is strongly affected by the cell’s nutrient status.

How is the Sumo pathway activated by stress, and how is specificity achieved?

It is still not very clear how specificity is achieved in the Sumo pathway. A very large number of proteins can be sumoylated, and an even larger number of proteins contains potential SIMs. Yet, specific stresses induce sumoylation of specific sets of proteins, and these sets of proteins may be different between various organisms. For instance, in yeast, DNA damage mainly induces sumoylation of DNA damage response proteins, such as proteins involved in HR [42], whereas in human cells the Sumo network primarily consists of chromatin modifiers and transcription factors [102].

In yeast, specificity towards HR proteins has been suggested to involve colocalization of Siz2 and HR proteins at ssDNA, and artificial targeting of HR proteins to DNA is sufficient to trigger their sumoylation [42]. Exactly how Ubc9 and Siz2 are regulated in this context remains unclear. It is possible that phosphorylation helps coordinate the Sumo pathway. In yeast, DNA damage checkpoint kinases, such as Tel1 (yeast ATM), Mec1 (yeast ATR), Chk1 and Rad53 (yeast Chk2) phosphorylate many proteins involved in the DNA damage response, including HR proteins [103]. Some of these phosphorylations may occur in PDSMs to promote subsequent sumoylation. Phosphorylation-mediated coordination of protein sumoylation could be a more general model for the Sumo stress response, since cellular stress activates several stress-induced kinases, such as p38 and JNK in mammals and Slt2 and Hog1 in yeast.

Locally, the activity of components of the sumoylation machinery may be regulated by post-translational modifications. In yeast, the E1 enzymes Uba2 and Aos1 have been found to be phosphorylated, although the functional consequences have not been explored [104106].

The E2 conjugase Ubc9 can be activated by phosphorylation. In mammalian cells, Akt phosphorylates Ubc9 on T35, which promotes thioester bond formation between Ubc9 and Sumo to increase Ubc9 activity [107]. This also promotes sumoylation of Ubc9 itself, which is believed to be important for substrate selection [108]. In addition to Ubc9, Akt can also phosphorylate Sumo-1 (on T76), which promotes the stability of Sumo-1. Thus, phosphorylation both activates Ubc9-Sumo and increases specificity of the sumoylation pathway. Cdk1 can also activate Ubc9 [109], although it phosphorylates Ubc9 on a different residues than Akt, i.e. S71, which falls within a full cyclin B-Cdk1 consensus site [110]. In contrast to phosphorylation by Akt, Cdk1-dependent phosphorylation does not result in increased autosumoylation of Ubc9 [109]. For both Akt- and Cdk1-dependent phosphorylation, the exact molecular mechanism by which phosphorylation activates Ubc9 remains to be revealed.

Other components of the sumoylation machinery are also kinase targets. For instance, the E3 ligase PIAS1 is phosphorylated by IKK on S90, which results in its localization to NF-κB-bound promoters where it inhibits transcription [111]. Furthermore, in yeast the desumoylating enzymes Ulp1 and Ulp2 have been found to be extensively phosphorylated, although the physiological relevance is unknown [106, 104, 103].

Finally, it worth mentioning that it was recently reported that in yeast the Sumo stress response critically depends upon active transcription, but does not require translation [112]. The authors observed that the osmotic shock-induced Sumo stress response does not appear to be directly linked to the stress itself, but rather represents a synchronized wave of sumoylation that occurs as a consequence of large-scale, coordinated changes in the transcriptional program in response to environmental stress [112]. This is an interesting observation, but it is presently difficult to understand how such transcriptional changes would result in sumoylation of specific protein complexes; for instance, why do osmotic shock-induced transcriptional changes not result in sumoylation of HR proteins, or other Sumo targets like septins [41]? More detailed follow-up studies are required to understand how active transcription is linked to protein group sumoylation.

Conclusions

Together, these studies show that Sumo plays an important role in maintaining cell homeostasis. Under optimal conditions, Sumo promotes cell growth and proliferation by activating pro-growth genes, whereas during cell stress Sumo contributes to activation of pro-survival pathways. Nonetheless, a lot remains to be learned about the Sumo stress response and regulation of the sumoylation machinery by phosphorylation and other post-translational modifications. Another major question that remains to be answered is how specificity is achieved.

Declarations

Authors’ Affiliations

(1)
Institute for Microbiology, Oslo University Hospital

References

  1. Meluh PB, Koshland D. Evidence that the MIF2 gene of Saccharomyces cerevisiae encodes a centromere protein with homology to the mammalian centromere protein CENP-C. Mol Biol Cell. 1995;6(7):793–807.PubMedPubMed CentralGoogle Scholar
  2. Bayer P, Arndt A, Metzger S, Mahajan R, Melchior F, Jaenicke R, et al. Structure determination of the small ubiquitin-related modifier SUMO-1. J Mol Biol. 1998;280(2):275–86. doi:https://doi.org/10.1006/jmbi.1998.1839.PubMedGoogle Scholar
  3. Gill G. SUMO and ubiquitin in the nucleus: different functions, similar mechanisms? Genes Dev. 2004;18(17):2046–59. doi:https://doi.org/10.1101/gad.1214604.PubMedGoogle Scholar
  4. Gareau JR, Lima CD. The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition. Nat Rev Mol Cell Biol. 2010;11(12):861–71. doi:https://doi.org/10.1038/nrm3011.PubMedPubMed CentralGoogle Scholar
  5. Mukhopadhyay D, Dasso M. Modification in reverse: the SUMO proteases. Trends Biochem Sci. 2007;32(6):286–95. doi:https://doi.org/10.1016/j.tibs.2007.05.002.PubMedGoogle Scholar
  6. Bachant J, Alcasabas A, Blat Y, Kleckner N, Elledge SJ. The SUMO-1 isopeptidase Smt4 is linked to centromeric cohesion through SUMO-1 modification of DNA topoisomerase II. Mol Cell. 2002;9(6):1169–82.PubMedGoogle Scholar
  7. Pelisch F, Sonneville R, Pourkarimi E, Agostinho A, Blow JJ, Gartner A, et al. Dynamic SUMO modification regulates mitotic chromosome assembly and cell cycle progression in Caenorhabditis elegans. Nat Commun. 2014;5:5485. doi:https://doi.org/10.1038/ncomms6485.PubMedPubMed CentralGoogle Scholar
  8. Texari L, Dieppois G, Vinciguerra P, Contreras MP, Groner A, Letourneau A, et al. The nuclear pore regulates GAL1 gene transcription by controlling the localization of the SUMO protease Ulp1. Mol Cell. 2013;51(6):807–18. doi:https://doi.org/10.1016/j.molcel.2013.08.047.PubMedGoogle Scholar
  9. Li SJ, Hochstrasser M. The yeast ULP2 (SMT4) gene encodes a novel protease specific for the ubiquitin-like Smt3 protein. Mol Cell Biol. 2000;20(7):2367–77.PubMedPubMed CentralGoogle Scholar
  10. Takahashi Y, Mizoi J, Toh EA, Kikuchi Y. Yeast Ulp1, an Smt3-specific protease, associates with nucleoporins. J Biochem. 2000;128(5):723–5.PubMedGoogle Scholar
  11. Rodriguez MS, Dargemont C, Hay RT. SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting. J Biol Chem. 2001;276(16):12654–9. doi:https://doi.org/10.1074/jbc.M009476200.PubMedGoogle Scholar
  12. Bernier-Villamor V, Sampson DA, Matunis MJ, Lima CD. Structural basis for E2-mediated SUMO conjugation revealed by a complex between ubiquitin-conjugating enzyme Ubc9 and RanGAP1. Cell. 2002;108(3):345–56.PubMedGoogle Scholar
  13. Lin D, Tatham MH, Yu B, Kim S, Hay RT, Chen Y. Identification of a substrate recognition site on Ubc9. J Biol Chem. 2002;277(24):21740–8. doi:https://doi.org/10.1074/jbc.M108418200.PubMedGoogle Scholar
  14. Sampson DA, Wang M, Matunis MJ. The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification. J Biol Chem. 2001;276(24):21664–9. doi:https://doi.org/10.1074/jbc.M100006200.PubMedGoogle Scholar
  15. Yang XJ, Gregoire S. A recurrent phospho-sumoyl switch in transcriptional repression and beyond. Mol Cell. 2006;23(6):779–86. doi:https://doi.org/10.1016/j.molcel.2006.08.009.PubMedGoogle Scholar
  16. Yang SH, Galanis A, Witty J, Sharrocks AD. An extended consensus motif enhances the specificity of substrate modification by SUMO. EMBO J. 2006;25(21):5083–93. doi:https://doi.org/10.1038/sj.emboj.7601383.PubMedPubMed CentralGoogle Scholar
  17. Castillo-Lluva S, Tatham MH, Jones RC, Jaffray EG, Edmondson RD, Hay RT, et al. SUMOylation of the GTPase Rac1 is required for optimal cell migration. Nat Cell Biol. 2010;12(11):1078–85. doi:https://doi.org/10.1038/ncb2112.PubMedPubMed CentralGoogle Scholar
  18. Zhu J, Zhu S, Guzzo CM, Ellis NA, Sung KS, Choi CY, et al. Small ubiquitin-related modifier (SUMO) binding determines substrate recognition and paralog-selective SUMO modification. J Biol Chem. 2008;283(43):29405–15. doi:https://doi.org/10.1074/jbc.M803632200.PubMedPubMed CentralGoogle Scholar
  19. Blomster HA, Imanishi SY, Siimes J, Kastu J, Morrice NA, Eriksson JE, et al. In vivo identification of sumoylation sites by a signature tag and cysteine-targeted affinity purification. J Biol Chem. 2010;285(25):19324–9. doi:https://doi.org/10.1074/jbc.M110.106955.PubMedPubMed CentralGoogle Scholar
  20. Hoege C, Pfander B, Moldovan GL, Pyrowolakis G, Jentsch S. RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. Nature. 2002;419(6903):135–41. doi:https://doi.org/10.1038/nature00991.PubMedGoogle Scholar
  21. Tammsalu T, Matic I, Jaffray EG, Ibrahim AF, Tatham MH, Hay RT. Proteome-wide identification of SUMO2 modification sites. Sci Signal. 2014;7(323):rs2. doi:https://doi.org/10.1126/scisignal.2005146.PubMedPubMed CentralGoogle Scholar
  22. Bencsath KP, Podgorski MS, Pagala VR, Slaughter CA, Schulman BA. Identification of a multifunctional binding site on Ubc9p required for Smt3p conjugation. J Biol Chem. 2002;277(49):47938–45. doi:https://doi.org/10.1074/jbc.M207442200.PubMedGoogle Scholar
  23. Tatham MH, Jaffray E, Vaughan OA, Desterro JM, Botting CH, Naismith JH, et al. Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9. J Biol Chem. 2001;276(38):35368–74. doi:https://doi.org/10.1074/jbc.M104214200.PubMedGoogle Scholar
  24. Perry JJ, Tainer JA, Boddy MN. A SIM-ultaneous role for SUMO and ubiquitin. Trends Biochem Sci. 2008;33(5):201–8. doi:https://doi.org/10.1016/j.tibs.2008.02.001.PubMedGoogle Scholar
  25. Tatham MH, Geoffroy MC, Shen L, Plechanovova A, Hattersley N, Jaffray EG, et al. RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation. Nat Cell Biol. 2008;10(5):538–46. doi:https://doi.org/10.1038/ncb1716.PubMedGoogle Scholar
  26. Lallemand-Breitenbach V, Jeanne M, Benhenda S, Nasr R, Lei M, Peres L, et al. Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway. Nat Cell Biol. 2008;10(5):547–55. doi:https://doi.org/10.1038/ncb1717.PubMedGoogle Scholar
  27. Fryrear KA, Guo X, Kerscher O, Semmes OJ. The Sumo-targeted ubiquitin ligase RNF4 regulates the localization and function of the HTLV-1 oncoprotein Tax. Blood. 2012;119(5):1173–81. doi:https://doi.org/10.1182/blood-2011-06-358564.PubMedPubMed CentralGoogle Scholar
  28. Elrouby N, Bonequi MV, Porri A, Coupland G. Identification of Arabidopsis SUMO-interacting proteins that regulate chromatin activity and developmental transitions. Proc Natl Acad Sci U S A. 2013;110(49):19956–61. doi:https://doi.org/10.1073/pnas.1319985110.PubMedPubMed CentralGoogle Scholar
  29. Gonzalez-Prieto R, Cuijpers SA, Kumar R, Hendriks IA, Vertegaal AC. c-Myc is targeted to the proteasome for degradation in a SUMOylation-dependent manner, regulated by PIAS1, SENP7 and RNF4. Cell cycle. 2015:0. doi:https://doi.org/10.1080/15384101.2015.1040965.
  30. Srikumar T, Lewicki MC, Costanzo M, Tkach JM, van Bakel H, Tsui K, et al. Global analysis of SUMO chain function reveals multiple roles in chromatin regulation. J Cell Biol. 2013;201(1):145–63. doi:https://doi.org/10.1083/jcb.201210019.PubMedPubMed CentralGoogle Scholar
  31. Moldovan GL, Pfander B, Jentsch S. PCNA controls establishment of sister chromatid cohesion during S phase. Mol Cell. 2006;23(5):723–32. doi:https://doi.org/10.1016/j.molcel.2006.07.007.PubMedGoogle Scholar
  32. Mohan RD, Rao A, Gagliardi J, Tini M. SUMO-1-dependent allosteric regulation of thymine DNA glycosylase alters subnuclear localization and CBP/p300 recruitment. Mol Cell Biol. 2007;27(1):229–43. doi:https://doi.org/10.1128/MCB.00323-06.PubMedPubMed CentralGoogle Scholar
  33. Minty A, Dumont X, Kaghad M, Caput D. Covalent modification of p73alpha by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif. J Biol Chem. 2000;275(46):36316–23. doi:https://doi.org/10.1074/jbc.M004293200.PubMedGoogle Scholar
  34. Song J, Durrin LK, Wilkinson TA, Krontiris TG, Chen Y. Identification of a SUMO-binding motif that recognizes SUMO-modified proteins. Proc Natl Acad Sci U S A. 2004;101(40):14373–8. doi:https://doi.org/10.1073/pnas.0403498101.PubMedPubMed CentralGoogle Scholar
  35. Reverter D, Lima CD. Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358 complex. Nature. 2005;435(7042):687–92. doi:https://doi.org/10.1038/nature03588.PubMedPubMed CentralGoogle Scholar
  36. Song J, Zhang Z, Hu W, Chen Y. Small ubiquitin-like modifier (SUMO) recognition of a SUMO binding motif: a reversal of the bound orientation. J Biol Chem. 2005;280(48):40122–9. doi:https://doi.org/10.1074/jbc.M507059200.PubMedGoogle Scholar
  37. Hannich JT, Lewis A, Kroetz MB, Li SJ, Heide H, Emili A, et al. Defining the SUMO-modified proteome by multiple approaches in Saccharomyces cerevisiae. J Biol Chem. 2005;280(6):4102–10. doi:https://doi.org/10.1074/jbc.M413209200.PubMedGoogle Scholar
  38. Hecker CM, Rabiller M, Haglund K, Bayer P, Dikic I. Specification of SUMO1- and SUMO2-interacting motifs. J Biol Chem. 2006;281(23):16117–27. doi:https://doi.org/10.1074/jbc.M512757200.PubMedGoogle Scholar
  39. Stehmeier P, Muller S. Phospho-regulated SUMO interaction modules connect the SUMO system to CK2 signaling. Mol Cell. 2009;33(3):400–9. doi:https://doi.org/10.1016/j.molcel.2009.01.013.PubMedGoogle Scholar
  40. Cremona CA, Sarangi P, Yang Y, Hang LE, Rahman S, Zhao X. Extensive DNA damage-induced sumoylation contributes to replication and repair and acts in addition to the mec1 checkpoint. Mol Cell. 2012;45(3):422–32. doi:https://doi.org/10.1016/j.molcel.2011.11.028.PubMedPubMed CentralGoogle Scholar
  41. Johnson ES, Blobel G. Cell cycle-regulated attachment of the ubiquitin-related protein SUMO to the yeast septins. J Cell Biol. 1999;147(5):981–94.PubMedPubMed CentralGoogle Scholar
  42. Psakhye I, Jentsch S. Protein group modification and synergy in the SUMO pathway as exemplified in DNA repair. Cell. 2012;151(4):807–20. doi:https://doi.org/10.1016/j.cell.2012.10.021.PubMedGoogle Scholar
  43. Hendriks IA, D'Souza RC, Yang B, Verlaan-de Vries M, Mann M, Vertegaal AC. Uncovering global SUMOylation signaling networks in a site-specific manner. Nat Struct Mol Biol. 2014;21(10):927–36. doi:https://doi.org/10.1038/nsmb.2890.PubMedPubMed CentralGoogle Scholar
  44. Saitoh H, Hinchey J. Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3. J Biol Chem. 2000;275(9):6252–8.PubMedGoogle Scholar
  45. Zhou W, Ryan JJ, Zhou H. Global analyses of sumoylated proteins in Saccharomyces cerevisiae. Induction of protein sumoylation by cellular stresses. J Biol Chem. 2004;279(31):32262–8. doi:https://doi.org/10.1074/jbc.M404173200.PubMedPubMed CentralGoogle Scholar
  46. Castro PH, Tavares RM, Bejarano ER, Azevedo H. SUMO, a heavyweight player in plant abiotic stress responses. Cell Mol Life Sci. 2012;69(19):3269–83. doi:https://doi.org/10.1007/s00018-012-1094-2.PubMedGoogle Scholar
  47. Miura K, Hasegawa PM. Sumoylation and other ubiquitin-like post-translational modifications in plants. Trends Cell Biol. 2010;20(4):223–32. doi:https://doi.org/10.1016/j.tcb.2010.01.007.PubMedGoogle Scholar
  48. Park HJ, Kim WY, Park HC, Lee SY, Bohnert HJ, Yun DJ. SUMO and SUMOylation in plants. Mol Cells. 2011;32(4):305–16. doi:https://doi.org/10.1007/s10059-011-0122-7.PubMedPubMed CentralGoogle Scholar
  49. Jackson SP, Durocher D. Regulation of DNA damage responses by ubiquitin and SUMO. Mol Cell. 2013;49(5):795–807. doi:https://doi.org/10.1016/j.molcel.2013.01.017.PubMedGoogle Scholar
  50. Sarangi P, Zhao X. SUMO-mediated regulation of DNA damage repair and responses. Trends Biochem Sci. 2015;40(4):233–42. doi:https://doi.org/10.1016/j.tibs.2015.02.006.PubMedGoogle Scholar
  51. Kats ES, Enserink JM, Martinez S, Kolodner RD. The Saccharomyces cerevisiae Rad6 Post Replication Repair and Siz1/Srs2 Homologous Recombination-inhibiting pathways process DNA damage that arises in asf1 mutants. Molecular and cellular biology. 2009. doi:MCB.00894-09 10.1128/MCB.00894-09.Google Scholar
  52. Krejci L, Van Komen S, Li Y, Villemain J, Reddy MS, Klein H, et al. DNA helicase Srs2 disrupts the Rad51 presynaptic filament. Nature. 2003;423(6937):305–9. doi:https://doi.org/10.1038/nature01577.PubMedGoogle Scholar
  53. Veaute X, Jeusset J, Soustelle C, Kowalczykowski SC, Le Cam E, Fabre F. The Srs2 helicase prevents recombination by disrupting Rad51 nucleoprotein filaments. Nature. 2003;423(6937):309–12. doi:https://doi.org/10.1038/nature01585.PubMedGoogle Scholar
  54. Pfander B, Moldovan GL, Sacher M, Hoege C, Jentsch S. SUMO-modified PCNA recruits Srs2 to prevent recombination during S phase. Nature. 2005;436(7049):428–33. doi:https://doi.org/10.1038/nature03665.PubMedGoogle Scholar
  55. Saponaro M, Callahan D, Zheng X, Krejci L, Haber JE, Klein HL et al. Cdk1 targets Srs2 to complete synthesis-dependent strand annealing and to promote recombinational repair. PLoS Genetics.6(2):e1000858. doi:https://doi.org/10.1371/journal.pgen.1000858.
  56. Kolesar P, Sarangi P, Altmannova V, Zhao X, Krejci L. Dual roles of the SUMO-interacting motif in the regulation of Srs2 sumoylation. Nucleic Acids Res. 2012;40(16):7831–43. doi:https://doi.org/10.1093/nar/gks484.PubMedPubMed CentralGoogle Scholar
  57. Xiao Z, Chang JG, Hendriks IA, Sigurethsson JO, Olsen JV, Vertegaal AC. System-wide Analysis of SUMOylation Dynamics in Response to Replication Stress Reveals Novel Small Ubiquitin-like Modified Target Proteins and Acceptor Lysines Relevant for Genome Stability. Mol Cell Proteomics. 2015;14(5):1419–34. doi:https://doi.org/10.1074/mcp.O114.044792.PubMedGoogle Scholar
  58. Van Damme E, Laukens K, Dang TH, Van Ostade X. A manually curated network of the PML nuclear body interactome reveals an important role for PML-NBs in SUMOylation dynamics. Int J Biol Sci. 2010;6(1):51–67.PubMedPubMed CentralGoogle Scholar
  59. Bernardi R, Pandolfi PP. Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat Rev Mol Cell Biol. 2007;8(12):1006–16. doi:https://doi.org/10.1038/nrm2277.PubMedGoogle Scholar
  60. Everett RD, Chelbi-Alix MK. PML and PML nuclear bodies: implications in antiviral defence. Biochimie. 2007;89(6–7):819–30. doi:https://doi.org/10.1016/j.biochi.2007.01.004.PubMedGoogle Scholar
  61. Lallemand-Breitenbach V, de The H. PML nuclear bodies. Cold Spring Harb Perspect Biol. 2010;2(5):a000661. doi:https://doi.org/10.1101/cshperspect.a000661.PubMedPubMed CentralGoogle Scholar
  62. Bonilla WV, Pinschewer DD, Klenerman P, Rousson V, Gaboli M, Pandolfi PP, et al. Effects of promyelocytic leukemia protein on virus-host balance. J Virol. 2002;76(8):3810–8.PubMedPubMed CentralGoogle Scholar
  63. Chu Y, Yang X. SUMO E3 ligase activity of TRIM proteins. Oncogene. 2011;30(9):1108–16. doi:https://doi.org/10.1038/onc.2010.462.PubMedPubMed CentralGoogle Scholar
  64. Pampin M, Simonin Y, Blondel B, Percherancier Y, Chelbi-Alix MK. Cross talk between PML and p53 during poliovirus infection: implications for antiviral defense. J Virol. 2006;80(17):8582–92. doi:https://doi.org/10.1128/JVI.00031-06.PubMedPubMed CentralGoogle Scholar
  65. Boggio R, Colombo R, Hay RT, Draetta GF, Chiocca S. A mechanism for inhibiting the SUMO pathway. Mol Cell. 2004;16(4):549–61. doi:https://doi.org/10.1016/j.molcel.2004.11.007.PubMedGoogle Scholar
  66. Boggio R, Passafaro A, Chiocca S. Targeting SUMO E1 to ubiquitin ligases: a viral strategy to counteract sumoylation. J Biol Chem. 2007;282(21):15376–82. doi:https://doi.org/10.1074/jbc.M700889200.PubMedGoogle Scholar
  67. Muller S, Dejean A. Viral immediate-early proteins abrogate the modification by SUMO-1 of PML and Sp100 proteins, correlating with nuclear body disruption. J Virol. 1999;73(6):5137–43.PubMedPubMed CentralGoogle Scholar
  68. Wimmer P, Schreiner S, Dobner T. Human pathogens and the host cell SUMOylation system. J Virol. 2012;86(2):642–54. doi:https://doi.org/10.1128/JVI.06227-11.PubMedPubMed CentralGoogle Scholar
  69. Everett RD, Boutell C, Hale BG. Interplay between viruses and host sumoylation pathways. Nat Rev Microbiol. 2013;11(6):400–11. doi:https://doi.org/10.1038/nrmicro3015.PubMedGoogle Scholar
  70. Hetz C. The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat Rev Mol Cell Biol. 2012;13(2):89–102. doi:https://doi.org/10.1038/nrm3270.PubMedGoogle Scholar
  71. Chen H, Qi L. SUMO modification regulates the transcriptional activity of XBP1. Biochem J. 2010;429(1):95–102. doi:https://doi.org/10.1042/BJ20100193.PubMedPubMed CentralGoogle Scholar
  72. Jiang Z, Fan Q, Zhang Z, Zou Y, Cai R, Wang Q, et al. SENP1 deficiency promotes ER stress-induced apoptosis by increasing XBP1 SUMOylation. Cell Cycle. 2012;11(6):1118–22. doi:https://doi.org/10.4161/cc.11.6.19529.PubMedGoogle Scholar
  73. Lim Y, Lee D, Kalichamy K, Hong SE, Michalak M, Ahnn J, et al. Sumoylation regulates ER stress response by modulating calreticulin gene expression in XBP-1-dependent mode in Caenorhabditis elegans. Int J Biochem Cell Biol. 2014;53:399–408. doi:https://doi.org/10.1016/j.biocel.2014.06.005.PubMedGoogle Scholar
  74. Moore KA, Plant JJ, Gaddam D, Craft J, Hollien J. Regulation of sumo mRNA during endoplasmic reticulum stress. PLoS One. 2013;8(9), e75723. doi:https://doi.org/10.1371/journal.pone.0075723.PubMedPubMed CentralGoogle Scholar
  75. Uemura A, Taniguchi M, Matsuo Y, Oku M, Wakabayashi S, Yoshida H. UBC9 regulates the stability of XBP1, a key transcription factor controlling the ER stress response. Cell Struct Funct. 2013;38(1):67–79.PubMedGoogle Scholar
  76. Gill G. Something about SUMO inhibits transcription. Curr Opin Genet Dev. 2005;15(5):536–41. doi:https://doi.org/10.1016/j.gde.2005.07.004.PubMedGoogle Scholar
  77. Hamard PJ, Boyer-Guittaut M, Camuzeaux B, Dujardin D, Hauss C, Oelgeschlager T, et al. Sumoylation delays the ATF7 transcription factor subcellular localization and inhibits its transcriptional activity. Nucleic Acids Res. 2007;35(4):1134–44. doi:https://doi.org/10.1093/nar/gkl1168.PubMedPubMed CentralGoogle Scholar
  78. Van Nguyen T, Angkasekwinai P, Dou H, Lin FM, Lu LS, Cheng J, et al. SUMO-specific protease 1 is critical for early lymphoid development through regulation of STAT5 activation. Mol Cell. 2012;45(2):210–21. doi:https://doi.org/10.1016/j.molcel.2011.12.026.PubMedPubMed CentralGoogle Scholar
  79. Desterro JM, Rodriguez MS, Hay RT. SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol Cell. 1998;2(2):233–9.PubMedGoogle Scholar
  80. Yang SH, Sharrocks AD. SUMO promotes HDAC-mediated transcriptional repression. Mol Cell. 2004;13(4):611–7.PubMedGoogle Scholar
  81. David G, Neptune MA, DePinho RA. SUMO-1 modification of histone deacetylase 1 (HDAC1) modulates its biological activities. J Biol Chem. 2002;277(26):23658–63. doi:https://doi.org/10.1074/jbc.M203690200.PubMedGoogle Scholar
  82. Sramko M, Markus J, Kabat J, Wolff L, Bies J. Stress-induced inactivation of the c-Myb transcription factor through conjugation of SUMO-2/3 proteins. J Biol Chem. 2006;281(52):40065–75. doi:https://doi.org/10.1074/jbc.M609404200.PubMedGoogle Scholar
  83. Goodson ML, Hong Y, Rogers R, Matunis MJ, Park-Sarge OK, Sarge KD. Sumo-1 modification regulates the DNA binding activity of heat shock transcription factor 2, a promyelocytic leukemia nuclear body associated transcription factor. J Biol Chem. 2001;276(21):18513–8. doi:https://doi.org/10.1074/jbc.M008066200.PubMedGoogle Scholar
  84. Hong Y, Rogers R, Matunis MJ, Mayhew CN, Goodson ML, Park-Sarge OK, et al. Regulation of heat shock transcription factor 1 by stress-induced SUMO-1 modification. J Biol Chem. 2001;276(43):40263–7. doi:https://doi.org/10.1074/jbc.M104714200.PubMedGoogle Scholar
  85. Huang TT, Wuerzberger-Davis SM, Wu ZH, Miyamoto S. Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress. Cell. 2003;115(5):565–76.PubMedGoogle Scholar
  86. Mabb AM, Wuerzberger-Davis SM, Miyamoto S. PIASy mediates NEMO sumoylation and NF-kappaB activation in response to genotoxic stress. Nat Cell Biol. 2006;8(9):986–93. doi:https://doi.org/10.1038/ncb1458.PubMedGoogle Scholar
  87. De Virgilio C, Loewith R. Cell growth control: little eukaryotes make big contributions. Oncogene. 2006;25(48):6392–415. doi:https://doi.org/10.1038/sj.onc.1209884.PubMedGoogle Scholar
  88. Willis IM, Moir RD. Integration of nutritional and stress signaling pathways by Maf1. Trends Biochem Sci. 2007;32(2):51–3. doi:https://doi.org/10.1016/j.tibs.2006.12.001.PubMedGoogle Scholar
  89. Loewith R, Hall MN. Target of rapamycin (TOR) in nutrient signaling and growth control. Genetics. 2011;189(4):1177–201. doi:https://doi.org/10.1534/genetics.111.133363.PubMedPubMed CentralGoogle Scholar
  90. Fullgrabe J, Klionsky DJ, Joseph B. The return of the nucleus: transcriptional and epigenetic control of autophagy. Nat Rev Mol Cell Biol. 2014;15(1):65–74. doi:https://doi.org/10.1038/nrm3716.PubMedGoogle Scholar
  91. Garbett KA, Tripathi MK, Cencki B, Layer JH, Weil PA. Yeast TFIID serves as a coactivator for Rap1p by direct protein-protein interaction. Mol Cell Biol. 2007;27(1):297–311. doi:https://doi.org/10.1128/MCB.01558-06.PubMedPubMed CentralGoogle Scholar
  92. Knight B, Kubik S, Ghosh B, Bruzzone MJ, Geertz M, Martin V, et al. Two distinct promoter architectures centered on dynamic nucleosomes control ribosomal protein gene transcription. Genes Dev. 2014;28(15):1695–709. doi:https://doi.org/10.1101/gad.244434.114.PubMedPubMed CentralGoogle Scholar
  93. Schawalder SB, Kabani M, Howald I, Choudhury U, Werner M, Shore D. Growth-regulated recruitment of the essential yeast ribosomal protein gene activator Ifh1. Nature. 2004;432(7020):1058–61. doi:https://doi.org/10.1038/nature03200.PubMedGoogle Scholar
  94. Wade JT, Hall DB, Struhl K. The transcription factor Ifh1 is a key regulator of yeast ribosomal protein genes. Nature. 2004;432(7020):1054–8. doi:https://doi.org/10.1038/nature03175.PubMedGoogle Scholar
  95. Chymkowitch P, Nguea PA, Aanes H, Koehler C, Thiede B, Lorenz S et al. Sumoylation of Rap1 mediates the recruitment of TFIID to promote transcription of ribosomal protein genes. Genome research. 2015. doi:10.1101/gr.185793.114.Google Scholar
  96. Lamoliatte F, Caron D, Durette C, Mahrouche L, Maroui MA, Caron-Lizotte O, et al. Large-scale analysis of lysine SUMOylation by SUMO remnant immunoaffinity profiling. Nat Commun. 2014;5:5409. doi:https://doi.org/10.1038/ncomms6409.PubMedGoogle Scholar
  97. Tatham MH, Matic I, Mann M, Hay RT. Comparative proteomic analysis identifies a role for SUMO in protein quality control. Sci Signal. 2011;4(178):rs4. doi:https://doi.org/10.1126/scisignal.2001484.PubMedGoogle Scholar
  98. Golebiowski F, Matic I, Tatham MH, Cole C, Yin Y, Nakamura A, et al. System-wide changes to SUMO modifications in response to heat shock. Sci Signal. 2009;2(72):ra24. doi:https://doi.org/10.1126/scisignal.2000282.PubMedGoogle Scholar
  99. Wen D, Xu Z, Xia L, Liu X, Tu Y, Lei H, et al. Important role of SUMOylation of Spliceosome factors in prostate cancer cells. J Proteome Res. 2014;13(8):3571–82. doi:https://doi.org/10.1021/pr4012848.PubMedGoogle Scholar
  100. Rohira AD, Chen CY, Allen JR, Johnson DL. Covalent small ubiquitin-like modifier (SUMO) modification of Maf1 protein controls RNA polymerase III-dependent transcription repression. J Biol Chem. 2013;288(26):19288–95. doi:https://doi.org/10.1074/jbc.M113.473744.PubMedPubMed CentralGoogle Scholar
  101. Lescasse R, Pobiega S, Callebaut I, Marcand S. End-joining inhibition at telomeres requires the translocase and polySUMO-dependent ubiquitin ligase Uls1. EMBO J. 2013;32(6):805–15. doi:https://doi.org/10.1038/emboj.2013.24.PubMedPubMed CentralGoogle Scholar
  102. Hendriks IA, Treffers LW, Verlaan-de Vries M, Olsen JV, Vertegaal AC. SUMO-2 Orchestrates Chromatin Modifiers in Response to DNA Damage. Cell reports. 2015. doi:10.1016/j.celrep.2015.02.033.Google Scholar
  103. Smolka MB, Albuquerque CP, Chen SH, Zhou H. Proteome-wide identification of in vivo targets of DNA damage checkpoint kinases. Proceedings of the National Academy of Sciences of the United States of America. 2007;104(25):10364–9. doi:0701622104 10.1073/pnas.0701622104.Google Scholar
  104. Holt LJ, Tuch BB, Villen J, Johnson AD, Gygi SP, Morgan DO. Global analysis of Cdk1 substrate phosphorylation sites provides insights into evolution. Science. 2009;325(5948):1682–6.PubMedPubMed CentralGoogle Scholar
  105. Swaney DL, Beltrao P, Starita L, Guo A, Rush J, Fields S, et al. Global analysis of phosphorylation and ubiquitylation cross-talk in protein degradation. Nat Methods. 2013;10(7):676–82. doi:https://doi.org/10.1038/nmeth.2519.PubMedGoogle Scholar
  106. Albuquerque CP, Smolka MB, Payne SH, Bafna V, Eng J, Zhou H. A multidimensional chromatography technology for in-depth phosphoproteome analysis. Molecular & cellular proteomics : MCP. 2008;7(7):1389–96. doi:M700468-MCP200 10.1074/mcp.M700468-MCP200.Google Scholar
  107. Lin CH, Liu SY, Lee EH. SUMO modification of Akt regulates global SUMOylation and substrate SUMOylation specificity through Akt phosphorylation of Ubc9 and SUMO1. Oncogene. 2015. doi:https://doi.org/10.1038/onc.2015.115.Google Scholar
  108. Knipscheer P, Flotho A, Klug H, Olsen JV, van Dijk WJ, Fish A, et al. Ubc9 sumoylation regulates SUMO target discrimination. Mol Cell. 2008;31(3):371–82. doi:https://doi.org/10.1016/j.molcel.2008.05.022.PubMedGoogle Scholar
  109. Su YF, Yang T, Huang H, Liu LF, Hwang J. Phosphorylation of Ubc9 by Cdk1 enhances SUMOylation activity. PLoS One. 2012;7(4), e34250. doi:https://doi.org/10.1371/journal.pone.0034250.PubMedPubMed CentralGoogle Scholar
  110. Enserink JM, Kolodner RD. An overview of Cdk1-controlled targets and processes. Cell Div. 2010;5:11. doi:1747-1028-5-11 10.1186/1747-1028-5-11.Google Scholar
  111. Liu B, Yang Y, Chernishof V, Loo RR, Jang H, Tahk S, et al. Proinflammatory stimuli induce IKKalpha-mediated phosphorylation of PIAS1 to restrict inflammation and immunity. Cell. 2007;129(5):903–14. doi:https://doi.org/10.1016/j.cell.2007.03.056.PubMedGoogle Scholar
  112. Lewicki MC, Srikumar T, Johnson E, Raught B. The S. cerevisiae SUMO stress response is a conjugation-deconjugation cycle that targets the transcription machinery. J Proteomics. 2015;118:39–48. doi:https://doi.org/10.1016/j.jprot.2014.11.012.PubMedGoogle Scholar
  113. Das-Bradoo S, Nguyen HD, Wood JL, Ricke RM, Haworth JC, Bielinsky AK. Defects in DNA ligase I trigger PCNA ubiquitylation at Lys 107. Nat Cell Biol. 2010;12(1):74–9. doi:https://doi.org/10.1038/ncb2007. sup pp 1–20.PubMedPubMed CentralGoogle Scholar

Copyright

© Enserink. 2015

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement